Are diabetes microvascular complications risk factors for fragility fracture?
Almutlaq N, Neyman A, DiMeglio LA.
Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):354-359. doi: 10.1097/MED.0000000000000642.
PMID:33989258
Fragility of Evidence for the Efficacy of Anti-Fracture Medications.
Tran N, Tran TS, Nguyen TV.
J Clin Endocrinol Metab. 2025 Dec 18;111(1):e70-e82. doi: 10.1210/clinem/dgaf332.
PMID:40488289
Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials.
Porcu G, Biffi A, Ronco R, Adami G, Alvaro R, Bogini R, Caputi AP, Frediani B, Gatti D, Gonnelli S, Iolascon G, Lenzi A, Leone S, Michieli R, Migliaccio S, Nicoletti T, Paoletta M, Pennini A, Piccirilli E, Rossini M, Tarantino U, Cianferotti L, Brandi ML, Corrao G.